Insider sales are negligible relative to market cap and likely reflect routine portfolio diversification. No actionable signal for traders.
ORKA drugs
ORKA drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jun 16 $67.71entry
- T+1 · 5mo ago +4.68%α +5.93% · $70.88
- T+5 · 5mo ago +23.17%α +25.40% · $83.40
- T+20 · 4mo ago +29.18%α +28.98% · $87.47
- T+60 · 2mo ago +35.36%α +34.36% · $91.65
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Four Oruka Therapeutics insiders (CEO, COO, General Counsel, and a Director) sold a total of ~$2.67M in open-market transactions over a 5-day window. The sales represent only 0.06% of the company's $4.2B market cap, making them immaterial and likely routine portfolio diversification.
Key Financial Metrics
Key Facts
- CEO Lawrence Klein sold 1,729 shares for ~$120K on June 15.
- COO Laura Sandler sold 600 shares for ~$42K on June 15.
- General Counsel Paul Quinlan sold 733 shares for ~$51K on June 15.
- Director Carl Dambkowski sold 35,000 shares (two transactions) for ~$2.45M on June 11-12.
- Total insider sales of ~$2.67M are 0.06% of ORKA's $4.2B market cap.
Financial Impact
Total insider sales of $2.67M represent 0.06% of market cap, immaterial.
Risk Factors
- No material risk from this cluster; sales are too small to indicate a bearish view.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-ORKA-1781564045890 |
Track record
40 reports on ORKA
7 of 10 bullish or bearish reports moved the stock their way by T+20. Best: +80.05% at T+60 after the Jun 1, 2026 report. 11 of 11 went positive at some point.
Filters
- Nov 16, 2026today SC 13G Neutral 3/10 Entry $102.46 Now $99.24 −3.14% settles Dec 15
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $104.40 Now $99.24 −4.94% settles Dec 15
- Nov 13, 20263d ago Insider Cluster Neutral 2/10 Entry $106.15 Now $99.24 −6.51% settles Dec 15
- Nov 13, 20263d ago Insider Cluster Neutral 2/10 Entry $104.89 Now $99.24 −5.39% settles Dec 15
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $105.35 Now $99.24 −5.80% settles Dec 14
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $105.35 Now $99.24 −5.80% settles Dec 14
- Nov 9, 20267d ago Press Release Neutral 5/10 Entry $109.50 Now $99.24 −9.37% settles Dec 9
- Nov 2, 202614d ago Institutional Cluster Neutral 2/10 Entry $99.55 Now $99.24 −0.31% settles Dec 2
- Nov 2, 202614d ago 144 Neutral 3/10 Entry $99.55 Now $99.24 −0.31% settles Dec 2
- Oct 26, 202621d ago 8-K Bullish 6/10 Entry $90.33 Now $99.24 +9.86% settles Nov 23
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers